ClassID:

109820

C12N2710/16271 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae; Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus Demonstrated effect

Recent Application in this class:
#1
20240408195
2024-12-12

EPSTEIN-BARR VIRUS VACCINES

#2
20240270796
2024-08-15

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

#3
20240076318
2024-03-07

Epstein-Barr Virus antigen constructs

#4
20230053688
2023-02-23

METHODS TO ALTER LATENCY IN EBV+ MALIGNANCIES

#5
20210198321
2021-07-01

Epstein-barr virus antigen constructs

#6
20210163542
2021-06-03

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

#7
20200330587
2020-10-22

Epstein-barr virus vaccines

#8
20200038505
2020-02-06

Virus-like particle compositions and vaccines against epstein-barr virus infection and disease

#9
20190381167
2019-12-19

METHOD FOR TREATING EPSTEIN-BARR VIRUS - POSITIVE CANCER WITH IMMUNOTHERAPY

#10
20190367561
2019-12-05

Vaccine compositions of herpesvirus envelope protein combinations to induce immune response

#11
20190263883
2019-08-29

METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION

#12
20180360950
2018-12-20

Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof

#13
20180078634
2018-03-22

Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease

#14
20170312355
2017-11-02

Method for treating epstein-barr virus—positive cancer with immunotherapy

#15
20160303224
2016-10-20

Epstein-Barr virus vaccines

#16
20160296618
2016-10-13

Epstein-Barr-virus vaccine

#17
20160199479
2016-07-14

T cell receptors

#18
20160022841
2016-01-28

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#19
20050208022
2005-09-22

Method for augmenting vision in persons suffering from photoreceptor cell degeneration